These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 331913)

  • 1. Control of cell differentiation in normal hematopoietic and leukemic cells.
    Sachs L
    Adv Pathobiol; 1977; (6):124-40. PubMed ID: 331913
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of Fc and C3 receptors on myeloid leukemic cells.
    Lotem J; Sachs L
    J Immunol; 1976 Aug; 117(2):580-6. PubMed ID: 950462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemo-lymphocytopoiesis. A review.
    Astaldi G; Yalçin B
    Haematologia (Budap); 1974; 8(1-4):461-6. PubMed ID: 4618233
    [No Abstract]   [Full Text] [Related]  

  • 4. Diversity in normal and leukemic hemopoiesis.
    McCulloch EA
    Prog Clin Biol Res; 1984; 148():59-70. PubMed ID: 6379674
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of normal differentiation of myeloid leukemic cells. XIII. Inducibility for some stages of differentiation by dimethylsulfoxide and its disassociation from inducibility by MGI.
    Maeda S; Sachs L
    J Cell Physiol; 1978 Feb; 94(2):181-5. PubMed ID: 304449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of normal differentiation of myeloid leukemic cells. XI. Induction of a specific requirement for cell viability and growth during the differentiation of myeloid leukemic cells.
    Fibach E; Sachs L
    J Cell Physiol; 1976 Oct; 89(2):259-66. PubMed ID: 972167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hemopoietic progenitor 32DCl3(G) cells synthesize C3 molecules and acquire C3b acceptor sites upon differentiation or neoplastic transformation.
    Di Renzo L; Zicari A; Longo A; Realacci M; Naso G; Pontieri G; Lipari M
    J Immunol; 1993 Oct; 151(7):3737-45. PubMed ID: 8376803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutants and the differentiation of the murine haematopoietic stem cell.
    Festing MF
    Exp Cell Biol; 1984; 52(1-2):62-72. PubMed ID: 6365648
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulatory control of the proliferation ad differentiation of normal and leukemia cells.
    Metcalf D
    Natl Cancer Inst Monogr; 1982; 60():123-31. PubMed ID: 6981771
    [No Abstract]   [Full Text] [Related]  

  • 10. [Normal and pathologic granulopoiesis. A review [].
    Góngora-Biachi RA; Hurtado-Monroy R; López-Karpovich X; González-Llaven J
    Rev Invest Clin; 1982; 34(2):187-96. PubMed ID: 6750735
    [No Abstract]   [Full Text] [Related]  

  • 11. Granulocyte-macrophage progenitor cell proliferation and differentiation.
    Francis GE; Guimaraes JE; Berney JJ; Granger S; Hoffbrand AV
    Haematol Blood Transfus; 1983; 28():355-7. PubMed ID: 6602742
    [No Abstract]   [Full Text] [Related]  

  • 12. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
    Kawagoe H; Potter M; Ellis J; Grosveld GC
    Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony-stimulating factor and differentiation-induction in myeloid leukemic cells.
    Nicola NA
    Int J Cell Cloning; 1987 Jan; 5(1):1-15. PubMed ID: 3031177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
    Koeffler HP; Hirji K; Itri L
    Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutants of a multipotent hematopoietic cell line blocked in GM-CSF-induced differentiation are leukemogenic in vivo.
    Just U; Spooncer E; Löhler J; Stocking C; Ostertag W; Dexter TM
    Exp Hematol; 1994 Aug; 22(9):933-40. PubMed ID: 8062891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of a hematopoietic-specific differentiation antigen of K562 cells in the human myeloid and lymphoid cell lineages.
    Clarke BJ; Liao SK; Leeds C; Soamboonsrup P; Neame PB
    Cancer Res; 1987 Aug; 47(16):4254-9. PubMed ID: 3475169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAMAL: evidence for an inhibitory role in normal granulopoiesis.
    Logan PM; Shellard J; Buskard N; Levy JG
    Exp Hematol; 1989 Dec; 17(11):1072-6. PubMed ID: 2684678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth, differentiation and the reversal of malignancy.
    Sachs L
    Sci Am; 1986 Jan; 254(1):40-7. PubMed ID: 3455670
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of hemopoietic cell proliferation and differentiation.
    Metcalf D
    Prog Clin Biol Res; 1981; 66 Pt A():473-86. PubMed ID: 7312871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic dissection of the control of normal differentiation in myeloid leukemic cells.
    Lotem J; Sachs L
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5554-8. PubMed ID: 271980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.